FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

[cafead]

via The U.S. Food and Drug Administration approved Moderna's (MRNA.O) respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

article source